Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$306,101,756
+$102,243,936 QoQ
Shares Held
255,206
+15.1% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#212
of 4,605 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FEDERATED HERMES, INC. holds $3,310,037,044 across 15 Drug Manufacturers - General names. LLY ranks #5 (9.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
4,461,449 | $1,122,679,024 | |
| 2 | PFE |
Pfizer Inc
|
20,825,845 | $501,486,346 | |
| 3 | AMGN |
Amgen Inc
|
1,372,553 | $497,028,892 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,852,266 | $366,516,180 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
255,206 | $306,101,756 | |
| 6 | JNJ |
Johnson & Johnson
|
732,891 | $186,132,326 | |
| 7 | SNY |
Sanofi
|
3,849,802 | $164,232,552 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
868,399 | $109,713,528 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $306,101,756 | 255,206 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $203,857,820 | 221,640 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $343,973,933 | 320,071 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $94,833,270 | 124,290 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $172,884,940 | 221,781 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $246,495,314 | 298,453 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $222,634,764 | 288,387 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $326,484,835 | 368,518 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $240,072,370 | 265,162 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $162,054,511 | 208,307 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $129,214,709 | 221,668 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $196,005,181 | 364,912 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $196,270,942 | 418,506 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $133,111,994 | 387,607 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $166,988,763 | 456,453 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $68,912,026 | 213,119 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $14,703,380 | 51,344 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $14,168,427 | 51,294 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $11,830,683 | 51,204 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $15,520,370 | 67,621 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $28,569,073 | 152,923 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $31,246,373 | 185,065 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $29,667,944 | 200,432 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $35,368,804 | 215,427 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $60,876,161 | 438,842 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||